Bcl6 and transcription factors that program TFH differentiation and function
Bcl6 和转录因子编程 TFH 分化和功能
基本信息
- 批准号:10488587
- 负责人:
- 金额:$ 59.96万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-08-01 至 2025-07-31
- 项目状态:未结题
- 来源:
- 关键词:AddressAntibodiesAntibody AffinityAntibody ResponseAutoimmunityB-LymphocytesBLR1 geneBiologyCD 200CD30LCD4 Positive T LymphocytesCD8-Positive T-LymphocytesCD8B1 geneCRISPR/Cas technologyCell CommunicationCell Differentiation processCell physiologyCellsChromatinCivilizationClustered Regularly Interspaced Short Palindromic RepeatsComplexDataDevelopmentDiseaseFutureGATA3 geneGenesHelper-Inducer T-LymphocyteHumanHumoral ImmunitiesImmune responseImmunityImmunobiologyImmunoglobulin Somatic HypermutationInterleukin-2KnowledgeLaboratoriesLightMedicalMemoryMemory B-LymphocyteModelingModernizationMolecularPathway interactionsPlasma CellsProcessProviderRUNX3 geneRegulationScourgeSeriesStructure of germinal center of lymph nodeT cell differentiationT-LymphocyteTNFSF11 geneTestingVaccinesViral AntibodiesWorkadaptive immunitybasecost effectiveeffector T cellexperimental studygenetic signatureimprovedinterleukin-21mouse modelpathogenprogrammed cell death protein 1programssynergismtooltranscription factorvaccine developmentvaccinologyvpr Genes
项目摘要
PROJECT SUMMARY / ABSTRACT
Project 1 (Crotty)
Helper T cell differentiation and function are important processes for many diseases. Vaccines are one of the
most cost effective medical treatments in modern civilization. The vast majority of current human vaccines
function by eliciting protective antibody responses. T cell help to B cells is a fundamental aspect of adaptive
immunity to many pathogens. Follicular helper CD4 T cells (Tfh) are the specialized providers of help to B cells.
Therefore, there is substantial potential for an improved understanding of Tfh cells to facilitate better anti-
pathogen immune responses and vaccine-elicited humoral immunity. Work by our laboratory and others
established that TFH cells depend on expression of the transcription factor Bcl6 and other transcription factors.
Despite these advances, the pathways that control TFH differentiation and define TFH functions remain poorly
understood. In Project 1, we will characterize, stratify, and interconnect TFs, chromatin regulators, and helper
molecules that control TFH differentiation and function, leveraging our current tools and our team’s knowledge of
related pathways in CD8 T cells (Projects 2 & 3). Aim 1. To understand the mechanisms of action of Bcl6 in TFH
cell differentiation and function. Bcl6 is the lineage defining transcription factor of TFH cells. How Bcl6
accomplishes control of TFH differentiation and function remains unclear, because of the complexity of the
biology. Based on preliminary data, our operating model is that Bcl6 controls TFH differentiation by repressor-of-
repressor mechanisms. Putative mechanisms will be comprehensively tested. Aim 2. Aim 1 has identified and
will identify key Bcl6-r TFs. In Aim 2 we explore the biology of these TFs and the putative mechanisms by which
these TFs control TFH. Aim 3. TFH help to B cells is a multifaceted process for which much is still unknown
regarding the molecules involved. This is in part because it is a complex set of functions, and in part because of
previous technological limitations. It is likely that elucidating the immunobiology underlying the differentiation of
Tfh cells and the process of generating protective antiviral antibody responses will reveal vaccinology principles
that can be applied to future vaccine development against infectious scourges.
项目总结/摘要
项目1(Crotty)
辅助T细胞的分化和功能是许多疾病的重要过程。疫苗是一种
最具成本效益的医疗方法。目前绝大多数人类疫苗
通过引发保护性抗体反应发挥作用。T细胞对B细胞的帮助是适应性免疫的一个基本方面。
对许多病原体的免疫力。滤泡辅助性CD 4 T细胞(Tfh)是专门帮助B细胞的提供者。
因此,有很大的潜力,提高对Tfh细胞的理解,以促进更好的抗肿瘤治疗。
病原体免疫应答和疫苗引起的体液免疫。我们实验室和其他机构的工作
建立了TFH细胞依赖于转录因子Bcl 6和其他转录因子的表达。
尽管有这些进展,控制TFH分化和定义TFH功能的途径仍然很差
明白在项目1中,我们将表征,分层,并互连TF,染色质调节剂和辅助因子。
控制TFH分化和功能的分子,利用我们目前的工具和我们团队的知识,
CD 8 T细胞相关通路(项目2和3)。目标1。了解Bcl 6在TFH中的作用机制
细胞分化和功能。Bcl 6是TFH细胞的谱系定义转录因子。如何Bcl 6
由于TFH分化和功能的复杂性,
生物学基于初步的数据,我们的操作模型是Bcl 6通过抑制因子-β 1来控制TFH分化。
阻遏机制将对假定的机制进行全面测试。目标2.目标1已确定,
将鉴定关键的Bcl 6-r TF。在目标2中,我们探索了这些TF的生物学和推测的机制,
这些TF控制TFH。目标3. TFH对B细胞的帮助是一个多方面的过程,其中许多仍然是未知的
关于所涉及的分子这部分是因为它是一组复杂的功能,部分是因为
以前的技术限制。很可能阐明免疫生物学的分化,
TFH细胞和产生保护性抗病毒抗体应答的过程将揭示疫苗学原理
可以应用于未来针对传染性疾病的疫苗开发。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Shane P Crotty其他文献
Shane P Crotty的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Shane P Crotty', 18)}}的其他基金
Immune engineering of optimized sequential immunization strategies for HIV vaccines
HIV疫苗序贯免疫策略优化的免疫工程
- 批准号:
10588202 - 财政年份:2021
- 资助金额:
$ 59.96万 - 项目类别:
Immune engineering of optimized sequential immunization strategies for HIV vaccines
HIV疫苗序贯免疫策略优化的免疫工程
- 批准号:
10383728 - 财政年份:2021
- 资助金额:
$ 59.96万 - 项目类别:
T follicular helper (Tfh) CD4+ T cell, germinal center, and antibody response dysfunction in human recurrent tonsillitis
人复发性扁桃体炎中滤泡辅助性 T (Tfh) CD4 T 细胞、生发中心和抗体反应功能障碍
- 批准号:
10304742 - 财政年份:2020
- 资助金额:
$ 59.96万 - 项目类别:
Bcl6 and transcription factors that program TFH differentiation and function
Bcl6 和转录因子编程 TFH 分化和功能
- 批准号:
10224892 - 财政年份:2020
- 资助金额:
$ 59.96万 - 项目类别:
Bcl6 and transcription factors that program TFH differentiation and function
Bcl6 和转录因子编程 TFH 分化和功能
- 批准号:
10683269 - 财政年份:2020
- 资助金额:
$ 59.96万 - 项目类别:
Transcription factor regulation of CD4 and CD8 T cell effector and memory differentiation and function
CD4 和 CD8 T 细胞效应及记忆分化和功能的转录因子调节
- 批准号:
10024583 - 财政年份:2020
- 资助金额:
$ 59.96万 - 项目类别:
相似海外基金
University of Aberdeen and Vertebrate Antibodies Limited KTP 23_24 R1
阿伯丁大学和脊椎动物抗体有限公司 KTP 23_24 R1
- 批准号:
10073243 - 财政年份:2024
- 资助金额:
$ 59.96万 - 项目类别:
Knowledge Transfer Partnership
Role of Natural Antibodies and B1 cells in Fibroproliferative Lung Disease
天然抗体和 B1 细胞在纤维增生性肺病中的作用
- 批准号:
10752129 - 财政年份:2024
- 资助金额:
$ 59.96万 - 项目类别:
CAREER: Next-generation protease inhibitor discovery with chemically diversified antibodies
职业:利用化学多样化的抗体发现下一代蛋白酶抑制剂
- 批准号:
2339201 - 财政年份:2024
- 资助金额:
$ 59.96万 - 项目类别:
Continuing Grant
Isolation and characterisation of monoclonal antibodies for the treatment or prevention of antibiotic resistant Acinetobacter baumannii infections
用于治疗或预防抗生素耐药鲍曼不动杆菌感染的单克隆抗体的分离和表征
- 批准号:
MR/Y008693/1 - 财政年份:2024
- 资助金额:
$ 59.96万 - 项目类别:
Research Grant
Developing first-in-class aggregation-specific antibodies for a severe genetic neurological disease
开发针对严重遗传神经系统疾病的一流聚集特异性抗体
- 批准号:
10076445 - 财政年份:2023
- 资助金额:
$ 59.96万 - 项目类别:
Grant for R&D
Discovery of novel nodal antibodies in the central nervous system demyelinating diseases and elucidation of the mechanisms through an optic nerve demyelination model
发现中枢神经系统脱髓鞘疾病中的新型节点抗体并通过视神经脱髓鞘模型阐明其机制
- 批准号:
23K14783 - 财政年份:2023
- 资助金额:
$ 59.96万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Elucidation of the mechanisms controlling the physicochemical properties and functions of supercharged antibodies and development of their applications
阐明控制超电荷抗体的理化性质和功能的机制及其应用开发
- 批准号:
23KJ0394 - 财政年份:2023
- 资助金额:
$ 59.96万 - 项目类别:
Grant-in-Aid for JSPS Fellows
Role of antibodies in hepatitis E virus infection
抗体在戊型肝炎病毒感染中的作用
- 批准号:
10639161 - 财政年份:2023
- 资助金额:
$ 59.96万 - 项目类别:
Defining the protective or pathologic role of antibodies in Post-Ebola Syndrome
定义抗体在埃博拉后综合症中的保护或病理作用
- 批准号:
10752441 - 财政年份:2023
- 资助金额:
$ 59.96万 - 项目类别:
Human CMV monoclonal antibodies as therapeutics to inhibit virus infection and dissemination
人 CMV 单克隆抗体作为抑制病毒感染和传播的治疗药物
- 批准号:
10867639 - 财政年份:2023
- 资助金额:
$ 59.96万 - 项目类别: